{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:06:07Z","timestamp":1772118367807,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Maharshi Dayanand University Rohtak","award":["FO\/UGC\/22\/1200 dated 27-5-22"],"award-info":[{"award-number":["FO\/UGC\/22\/1200 dated 27-5-22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02882-y","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T09:02:38Z","timestamp":1702285358000},"page":"3695-3707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases"],"prefix":"10.1007","volume":"397","author":[{"given":"Nisha","family":"Gulati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"2882_CR1","doi-asserted-by":"publisher","first-page":"e00749","DOI":"10.1016\/j.btre.2022.e00749","volume":"35","author":"DH Abou Baker","year":"2022","unstructured":"Abou Baker DH (2022) Can natural products modulate cytokine storm in SARS-CoV2 patients? Biotechnol Reports 35:e00749. https:\/\/doi.org\/10.1016\/j.btre.2022.e00749","journal-title":"Biotechnol Reports"},{"key":"2882_CR2","doi-asserted-by":"publisher","first-page":"205031212096575","DOI":"10.1177\/2050312120965752","volume":"8","author":"MN Amin","year":"2020","unstructured":"Amin MN, Siddiqui SA, Ibrahim M, Hakim ML, Ahammed MS, Kabir A, Sultana F (2020) Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer. SAGE Open Med 8:205031212096575. https:\/\/doi.org\/10.1177\/2050312120965752","journal-title":"SAGE Open Med"},{"key":"2882_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.humimm.2019.04.018","volume":"80","author":"R Ayakannu","year":"2019","unstructured":"Ayakannu R, Abdullah NA, Radhakrishnan AK, Raj VL, Liam CK (2019) Relationship between various cytokines implicated in asthma. Hum Immunol 80:755\u2013763. https:\/\/doi.org\/10.1016\/j.humimm.2019.04.018","journal-title":"Hum Immunol"},{"key":"2882_CR4","doi-asserted-by":"publisher","unstructured":"Bagnasco D, Paggiaro P, Latorre M et al (2021) Severe asthma: One disease and multiple definitions. World Allergy Organ J 14(11):100606.\u00a0https:\/\/doi.org\/10.1016\/j.waojou.2021.100606","DOI":"10.1016\/j.waojou.2021.100606"},{"key":"2882_CR5","doi-asserted-by":"publisher","unstructured":"Bergantini L, d'Alessandro M, Cameli P, Otranto A, Luzzi S, Bianchi F, Bargagli E. (2022) Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: the IL-8\/IL-32 axis. Cytokine 151. https:\/\/doi.org\/10.1016\/jcyto2022155804","DOI":"10.1016\/jcyto2022155804"},{"key":"2882_CR6","doi-asserted-by":"publisher","unstructured":"Boni FG, Hamdi I, Koundi LM, Shrestha K, Xie J. (2022)Cytokine storm in tuberculosis and IL-6 involvement. Infect GenetEvol 97. https:\/\/doi.org\/10.1016\/jmeegid2021105166","DOI":"10.1016\/jmeegid2021105166"},{"key":"2882_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/path.5364","volume":"250","author":"CA Brandsma","year":"2020","unstructured":"Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W (2020) Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol 250:624\u2013635. https:\/\/doi.org\/10.1002\/path.5364","journal-title":"J Pathol"},{"key":"2882_CR8","doi-asserted-by":"publisher","first-page":"100502","DOI":"10.1016\/j.waojou.2020.100502","volume":"14","author":"M Caminati","year":"2021","unstructured":"Caminati M, Morais-Almeida M, Bleecker E, AnsoteguiI CGW, Bovo C, Senna G (2021) Biologics and global burden of asthma: a worldwide portrait and a call for action. World Allergy Organ J 14:100502. https:\/\/doi.org\/10.1016\/j.waojou.2020.100502","journal-title":"World Allergy Organ J"},{"key":"2882_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22834-5","volume":"12","author":"E Conde","year":"2021","unstructured":"Conde E, Bertrand R, Balbino B, Bonnefoy J, Stackowicz J, Caillot N, Colaone F, Hamdi S, Houmadi R, Loste A, Kamphuis JB (2021) Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. NatCommun 12:1\u201314. https:\/\/doi.org\/10.1038\/s41467-021-22834-5","journal-title":"NatCommun"},{"key":"2882_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cyto.2021.155520","volume":"143","author":"RE Dawson","year":"2021","unstructured":"Dawson RE, Jenkins BJ, Saad MI (2021) IL-6 family cytokines in respiratory health and disease. Cytokine 143:27\u201331. https:\/\/doi.org\/10.1016\/j.cyto.2021.155520","journal-title":"Cytokine"},{"key":"2882_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ijid.2022.06.053","volume":"122","author":"L Ding","year":"2022","unstructured":"Ding L, Chen Y, Su N, Xu X, Yin J, Qiu J, Wang J, Zheng D (2022) Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A ( H7N9) virus infection. Int J Infectious Diseases 122:593\u2013598. https:\/\/doi.org\/10.1016\/j.ijid.2022.06.053","journal-title":"Int J Infectious Diseases"},{"key":"2882_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.xphs.2021.09.012","volume":"111","author":"S D'Souza","year":"2022","unstructured":"D\u2019Souza S, Du Plessis SM, Egieyeh S, Bekale RB, Maphasa RE, Irabin AF, Sampson SL, Dube A (2022) Physicochemical and biological evaluation of curdlan-poly(lactic-co-glycolic acid) nanoparticles as a host-directed therapy against Mycobacterium tuberculosis. J Pharm Sci 111:469\u2013478. https:\/\/doi.org\/10.1016\/j.xphs.2021.09.012","journal-title":"J Pharm Sci"},{"issue":"12","key":"2882_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/nnm-2022-0165","volume":"17","author":"K Dua","year":"2022","unstructured":"Dua K, Lobenberg R, Chellappan DK (2022) Special focus issue on targeted drug delivery for inflammatory lung diseases. Nanomedicine 17(12):813\u2013815. https:\/\/doi.org\/10.2217\/nnm-2022-0165","journal-title":"Nanomedicine"},{"key":"2882_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.trsl.2015.08.004","volume":"167","author":"AL Durham","year":"2016","unstructured":"Durham AL, Caramori G, Chung KF, Adcock IM (2016) Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease. Transl Res 167:192\u2013203. https:\/\/doi.org\/10.1016\/j.trsl.2015.08.004","journal-title":"Transl Res"},{"key":"2882_CR15","doi-asserted-by":"publisher","unstructured":"Gauvreau GM, Bergeron C, Boulet LP, Cockcroft DW, C\u00f4t\u00e9 A, Davis BE, Leigh R, Myers I, O'Byrne PM, Sehmi R (2022) Sounding the alarmins\u2014the role of alarmin cytokines in asthma. Allergy Eur J Allergy Clin Immunol 402\u2013417. https:\/\/doi.org\/10.1111\/all15609","DOI":"10.1111\/all15609"},{"key":"2882_CR16","doi-asserted-by":"publisher","unstructured":"Ghozikali MG, Ansarin K, Naddafi K, Nabizadeh R, Yaghmaeian K, Jaafari J, Dehghanzadeh R, Atafar Z, Faraji M, Mohammadi A, Goudarzi G. (2022) Status of TNF-\u03b1 and IL-6 as pro-inflammatory cytokines in exhaled breath condensate of late adolescents with asthma and healthy in the dust storm and non-dust storm conditions. Sci Total Environ 838. https:\/\/doi.org\/10.1016\/jscitotenv2022155536","DOI":"10.1016\/jscitotenv2022155536"},{"key":"2882_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/jijpharm201812042","volume":"557","author":"RC Gopalan","year":"2019","unstructured":"Gopalan RC, Najafzadeh M, Mohammad MA, Anderson D, Paradkar A, Assi KH (2019) Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of nanoparticles. Int J Pharm 557:254\u2013263. https:\/\/doi.org\/10.1016\/jijpharm201812042","journal-title":"Int J Pharm"},{"key":"2882_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/jcophys202105001","volume":"22","author":"DM Gray","year":"2021","unstructured":"Gray DM, Owusu SK, van der Zalm MM (2021) Chronic lung disease in children: disease focused use of lung function. CurrOpinPhysiol 22:1\u20139. https:\/\/doi.org\/10.1016\/jcophys202105001","journal-title":"CurrOpinPhysiol"},{"key":"2882_CR19","doi-asserted-by":"publisher","first-page":"119969","DOI":"10.1016\/j.lfs.2021.119969","volume":"285","author":"N Gulati","year":"2021","unstructured":"Gulati N, Chellappan DK, MacLoughlin R, Dua K, Dureja H, Gulati N, Chellappan DK, MacLoughlin R, Dua K, Dureja H (2021a) Inhaled nano-based therapeutics for inflammatory lung diseases: recent advances and future prospects. Life Sci. 285:119969. https:\/\/doi.org\/10.1016\/j.lfs.2021.119969","journal-title":"Life Sci."},{"key":"2882_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijbiomac.2021.06.035","volume":"185","author":"N Gulati","year":"2021","unstructured":"Gulati N, Dua K, Dureja H (2021b) Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases. Int J Biol Macromol 185:20\u201330. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.035","journal-title":"Int J Biol Macromol"},{"key":"2882_CR21","doi-asserted-by":"publisher","unstructured":"Gulati N, Kumar Chellappan D, M. Tambuwala M, AA Aljabali A, Prasher P, Kumar Singh S, Anand K, Sharma A, Kumar Jha N, Gupta G, Dua K. (2021c) Oral nanoemulsion of fenofibrate: formulation, characterization, and in vitro drug release studies, 19: 246\u2013261 https:\/\/doi.org\/10.1089\/adt.2021.012","DOI":"10.1089\/adt.2021.012"},{"issue":"1","key":"2882_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/pharmaceutics14010106","volume":"14","author":"AA Halwani","year":"2022","unstructured":"Halwani AA (2022) Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics 14(1):106. https:\/\/doi.org\/10.3390\/pharmaceutics14010106","journal-title":"Pharmaceutics"},{"key":"2882_CR23","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1016\/jcclet202203108","volume":"33","author":"L Hang","year":"2022","unstructured":"Hang L, Shen C, Shen B, Yuan H (2022) Insight into the in vivo fate of intravenous herpetrione amorphous nanosuspensions by aggregation-caused quenching probes. Chinese Chem Lett 33:4948\u20134951. https:\/\/doi.org\/10.1016\/jcclet202203108","journal-title":"Chinese Chem Lett"},{"key":"2882_CR24","doi-asserted-by":"publisher","unstructured":"Hasan MJ (2020) Tocilizumab in COVID-19 treatment: a cost-burden in low-and middle-income countries. Int J Health Life Sci 6(2). https:\/\/doi.org\/10.5812\/ijhls.104480","DOI":"10.5812\/ijhls.104480"},{"key":"2882_CR25","doi-asserted-by":"publisher","unstructured":"Hildenbrand K, Aschenbrenner I, Franke FC, Devergne O, Feige MJ (2022) Biogenesis and engineering of interleukin 12 family cytokines. Trends Biochem Sci 1\u201314. https:\/\/doi.org\/10.1016\/jtibs202205005","DOI":"10.1016\/jtibs202205005"},{"key":"2882_CR26","doi-asserted-by":"publisher","first-page":"118923","DOI":"10.1016\/jlfs2020118923","volume":"267","author":"R Hirawat","year":"2021","unstructured":"Hirawat R, Saifi MA, Godugu C (2021) Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications. Life Sci 267:118923. https:\/\/doi.org\/10.1016\/jlfs2020118923","journal-title":"Life Sci"},{"key":"2882_CR27","doi-asserted-by":"publisher","unstructured":"Hossain MM, Nesa F, Das J, Aggad R, Tasnim S, Bairwa M, Ma P, Ramirez G (2022) Global burden of mental health problems among children and adolescents during COVID-19 pandemic: a systematic umbrella review, MedRxiv.\u00a0https:\/\/doi.org\/10.1101\/2022.04.22.22274169","DOI":"10.1101\/2022.04.22.22274169"},{"key":"2882_CR28","doi-asserted-by":"publisher","unstructured":"Hussain MS, Sharma P, Dhanjal DS, Khurana N, Vyas M, Sharma N, Mehta M, Tambuwala MM, Satija S, Sohal SS, Oliver BG (2021) Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. Chem Biol Interact 348. https:\/\/doi.org\/10.1016\/jcbi2021109637","DOI":"10.1016\/jcbi2021109637"},{"key":"2882_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7206451","author":"L Jiang","year":"2020","unstructured":"Jiang L, Shao Y, Tian Y, Ouyang C, Wang X (2020) Nuclear alarmin cytokines in inflammation. J Immunol Res. https:\/\/doi.org\/10.1155\/2020\/7206451","journal-title":"J Immunol Res"},{"key":"2882_CR30","doi-asserted-by":"publisher","first-page":"108703","DOI":"10.1016\/jecolind2022108703","volume":"137","author":"A Kaklauskas","year":"2022","unstructured":"Kaklauskas A, Milevicius V, Kaklauskiene L (2022) Effects of country success on COVID-19 cumulative cases and excess deaths in 169 countries. Ecol Indic 137:108703. https:\/\/doi.org\/10.1016\/jecolind2022108703","journal-title":"Ecol Indic"},{"key":"2882_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20236008","volume":"20","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B (2019) Cytokines in inflammatory disease. Int J Mol Sci 20:1\u201331. https:\/\/doi.org\/10.3390\/ijms20236008","journal-title":"Int J Mol Sci"},{"key":"2882_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.05.011","author":"E Kehagia","year":"2023","unstructured":"Kehagia E, Papakyriakopoulou P, Valsami G (2023) Advances in intranasal vaccine delivery: a promising non-invasive route of immunization. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.011","journal-title":"Vaccine"},{"key":"2882_CR33","doi-asserted-by":"publisher","unstructured":"Kumar RK, Herbert C (2017) Airway epithelial cytokines in asthma and chronic obstructive pulmonary disease, cytokine effector functions in tissues. 163\u2013172. https:\/\/doi.org\/10.1016\/B978-0-12-804214-400010-5","DOI":"10.1016\/B978-0-12-804214-400010-5"},{"key":"2882_CR34","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht BN, Hammad H, Fahy JV (2019) The cytokines of asthma. Immunity 50:975\u2013991. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.018","journal-title":"Immunity"},{"key":"2882_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijid.2020.07.081","volume":"99","author":"A Langer-Gould","year":"2020","unstructured":"Langer-Gould A, Smith JB, Gonzales EG, Castillo RD, Figueroa JG, Ramanathan A, Li BH, Gould MK (2020) Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab. Int J Infect Dis 99:291\u2013297. https:\/\/doi.org\/10.1016\/j.ijid.2020.07.081","journal-title":"Int J Infect Dis"},{"key":"2882_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ijbiomac.2022.01.194","volume":"202","author":"Y Li","year":"2022","unstructured":"Li Y, Guo C, Chen Q, Su Y, Guo H, Liu R, Sun C, Mi S, Wang J, Chen D (2022) Improvement of pneumonia by curcumin-loaded bionanosystems based on platycodon grandiflorum polysaccharides via calming cytokine storm. Int J BiolMacromol 202:691\u2013706. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.194","journal-title":"Int J BiolMacromol"},{"key":"2882_CR37","doi-asserted-by":"publisher","unstructured":"Liao H, Ye J, Gao Y, Lian C, Liu L, Xu X, Feng Y, Yang Y, Yang Y, Shen Q, Gao L (2022) Baicalein self\u2010microemulsion based on drug\u2013phospholipid complex for the alleviation of cytokine storm. BioengTransl Med 1\u201319. https:\/\/doi.org\/10.1002\/btm210357","DOI":"10.1002\/btm210357"},{"key":"2882_CR38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.gendis.2020.06.009","volume":"7","author":"SH Lin","year":"2020","unstructured":"Lin SH, Zhao YS, Zhou DX, Zhou FC, Xu F (2020) Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. Genes Dis 7:520\u2013527. https:\/\/doi.org\/10.1016\/j.gendis.2020.06.009","journal-title":"Genes Dis"},{"key":"2882_CR39","doi-asserted-by":"publisher","unstructured":"Liu D, Long M, Gao L, Chen Y, Li F, Shi Y, Gu N (2022) Nanomedicines targeting respiratory injuries for pulmonary disease management. AdvFunct Mater 32. https:\/\/doi.org\/10.1002\/adfm202112258","DOI":"10.1002\/adfm202112258"},{"key":"2882_CR40","doi-asserted-by":"publisher","unstructured":"Ma Q, Fan Q, Xu J, Bai J, Han X, Dong Z, Zhou X, Liu Z, Gu Z, Wang C (2020) Calming cytokine storm in pneumonia by targeted delivery of TPCA-1 using platelet-derived extracellular vesicles. Matter 287\u2013301. https:\/\/doi.org\/10.1016\/jmatt202005017","DOI":"10.1016\/jmatt202005017"},{"issue":"6","key":"2882_CR41","first-page":"257","volume":"7","author":"T Madaan","year":"2015","unstructured":"Madaan T, Pandey S, Talegaonkar S, Delhi N (2015) Nanotechnology: a smart drug delivery tool in modern healthcare. J Chem Pharm Res 7(6):257\u2013264","journal-title":"J Chem Pharm Res"},{"key":"2882_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","volume":"53","author":"N Mangalmurti","year":"2020","unstructured":"Mangalmurti N, Hunter CA (2020) Cytokine storms: understanding COVID-19. Immunity 53:19\u201325. https:\/\/doi.org\/10.1016\/j.immuni.2020.06.017","journal-title":"Immunity"},{"key":"2882_CR43","doi-asserted-by":"publisher","unstructured":"Matarazzo L, Santana YE, Walsh PT, Fallon PG(2022) The IL-1 cytokine family as custodians of barrier immunity. Cytokine154. https:\/\/doi.org\/10.1016\/jcyto2022155890","DOI":"10.1016\/jcyto2022155890"},{"key":"2882_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/mi12040435","volume":"12","author":"I Menon","year":"2021","unstructured":"Menon I, Bagwe P, Gomes KB, Bajaj L, Gala R, Uddin MN, D\u2019souza MJ, Zughaier (2021) SM, Microneedles: a new generation vaccine delivery system. Micromachines 12:1\u201318. https:\/\/doi.org\/10.3390\/mi12040435","journal-title":"Micromachines"},{"key":"2882_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2021.09.001","volume":"241","author":"JE Michalski","year":"2022","unstructured":"Michalski JE, Kurche JS, Schwartz DA (2022) From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 241:13\u201324. https:\/\/doi.org\/10.1016\/j.trsl.2021.09.001","journal-title":"Transl Res"},{"key":"2882_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/jactbio202206024","author":"W Muhammad","year":"2022","unstructured":"Muhammad W, Zhu J, Zhai Z, Xie J, Zhou J, Feng X, Feng B, Pan Q, Li S, Venkatesan R, Li P (2022) ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment. Acta Biomater. https:\/\/doi.org\/10.1016\/jactbio202206024","journal-title":"Acta Biomater"},{"key":"2882_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejpb.2022.04.009","volume":"175","author":"LN Nodilo","year":"2022","unstructured":"Nodilo LN, Perku\u0161i\u0107 M, Ugrina I, \u0160poljari\u0107 D, Brala CJ, Klari\u0107 DA, Lovri\u0107 J, Sar\u0161on V, Ku\u010duk MS, Zadravec D, Kalogjera L (2022) In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery. Eur J PharmBiopharm 175:27\u201342. https:\/\/doi.org\/10.1016\/j.ejpb.2022.04.009","journal-title":"Eur J PharmBiopharm"},{"key":"2882_CR48","doi-asserted-by":"publisher","first-page":"106247","DOI":"10.1016\/jejps2022106247","volume":"176","author":"P Party","year":"2022","unstructured":"Party P, K\u00f3kai D, Buri\u00e1n K, Nagy A, Hopp B, Ambrus R (2022) Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: in vitro aerodynamic and cell line measurements. Eur J Pharm Sci 176:106247. https:\/\/doi.org\/10.1016\/jejps2022106247","journal-title":"Eur J Pharm Sci"},{"key":"2882_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/jheliyon2021e06158","author":"S Patel","year":"2021","unstructured":"Patel S, Saxena B, Mehta P (2021) Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon. https:\/\/doi.org\/10.1016\/jheliyon2021e06158","journal-title":"Heliyon"},{"issue":"1","key":"2882_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):1\u201333. https:\/\/doi.org\/10.1186\/s12951-018-0392-8","journal-title":"J Nanobiotechnol"},{"key":"2882_CR51","doi-asserted-by":"publisher","unstructured":"Paudel KR, Mehta M, Shukla SD, Panth N, Chellappan DK, Dua K, Hansbro P. (2022) Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease. Nanomedicine 38\u201341. https:\/\/doi.org\/10.2217\/nnm-2021-0373","DOI":"10.2217\/nnm-2021-0373"},{"key":"2882_CR52","doi-asserted-by":"publisher","first-page":"102351","DOI":"10.1016\/jnano2020102351","volume":"33","author":"V Pooladanda","year":"2021","unstructured":"Pooladanda V, Thatikonda S, Sunnapu O, Tiwary S, Vemula PK, Talluri MK, Godugu C (2021) iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome, Nanomedicine Nanotechnology. Biol Med 33:102351. https:\/\/doi.org\/10.1016\/jnano2020102351","journal-title":"Biol Med"},{"key":"2882_CR53","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/j.apsb.2021.04.023","volume":"11","author":"Q Qiao","year":"2021","unstructured":"Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang C, Zhang Z (2021) Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design. Acta Pharm Sin B 11:3060\u20133091. https:\/\/doi.org\/10.1016\/j.apsb.2021.04.023","journal-title":"Acta Pharm Sin B"},{"key":"2882_CR54","doi-asserted-by":"publisher","unstructured":"Rana P, Chauhan S, Mubayi A (2022) Burden of cytokines storm on prognosis of SARS-CoV-2 infection through immune response: dynamic analysis and optimal control with immunomodulatory therapy. Eur Phys J Spec Top 123. https:\/\/doi.org\/10.1140\/epjs\/s11734-022-00435-7","DOI":"10.1140\/epjs\/s11734-022-00435-7"},{"key":"2882_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12121206","volume":"12","author":"ST Rasool","year":"2020","unstructured":"Rasool ST, Alavala RR, Kulandaivelu U, Sreeharsha N (2020) Non-invasive delivery of nano-emulsified sesame oil-extract of turmeric attenuates lung inflammation. Pharmaceutics 12:1\u201315. https:\/\/doi.org\/10.3390\/pharmaceutics12121206","journal-title":"Pharmaceutics"},{"key":"2882_CR56","doi-asserted-by":"publisher","unstructured":"Ravichandran S, Manickam N, Kandasamy M (2022) Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: a promising pharmacological regime to defuse cytokine storm in COVID-19. Med Drug Dis 100136. https:\/\/doi.org\/10.1016\/jmedidd2022100136","DOI":"10.1016\/jmedidd2022100136"},{"key":"2882_CR57","doi-asserted-by":"publisher","unstructured":"Ritzmann F, Beisswenger C (2021) Preclinical studies and the function of IL-17 cytokines in COPD. AnnAnat 237. https:\/\/doi.org\/10.1016\/j.aanat.2021.151729","DOI":"10.1016\/j.aanat.2021.151729"},{"key":"2882_CR58","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1021\/acssensors.0c00979","volume":"5","author":"SM Russell","year":"2020","unstructured":"Russell SM, Alba-Pati\u00f1o A, Baron E, Borges M, Gonzalez-Freire M, De La Rica R (2020) Biosensors for managing the COVID-19 cytokine storm: challenges ahead. ACS Sensors 5:1506\u20131513. https:\/\/doi.org\/10.1021\/acssensors.0c00979","journal-title":"ACS Sensors"},{"key":"2882_CR59","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2020.09.013","volume":"25","author":"N Sanghai","year":"2020","unstructured":"Sanghai N, Tranmer GK (2020) Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms. Drug Discov Today 25:2076\u20132079. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.013","journal-title":"Drug Discov Today"},{"key":"2882_CR60","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/jjiph202203014","volume":"15","author":"SK Sharma","year":"2022","unstructured":"Sharma SK, Bhatt P, Asdaq SM, Alshammari MK, Alanazi A, Alrasheedi NS, Alrashdi BA, Alyami SS, Alhazmi BH, Alam P, Sharma P (2022) Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: a narrative review. J Infect Public Health 15:566\u2013572. https:\/\/doi.org\/10.1016\/jjiph202203014","journal-title":"J Infect Public Health"},{"key":"2882_CR61","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/stem.3354","volume":"39","author":"N Song","year":"2021","unstructured":"Song N, Wakimoto H, Rossignoli F, Bhere D, Ciccocioppo R, Chen KS, Khalsa JK, Mastrolia I, Samarelli AV, Dominici M, Shah K (2021) Mesenchymal stem cell immunomodulation: in pursuit of controlling COVID-19 related cytokine storm. Stem Cells 39:707\u2013722. https:\/\/doi.org\/10.1002\/stem.3354","journal-title":"Stem Cells"},{"key":"2882_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/jcytogfr202004002","volume":"53","author":"X Sun","year":"2020","unstructured":"Sun X, Wang T, Cai D, Hu Z, Liao H, Zhi L, Wei H, Zhang Z, Qiu Y, Wang J, Wang A (2020) Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev 53:38\u201342. https:\/\/doi.org\/10.1016\/jcytogfr202004002","journal-title":"Cytokine Growth Factor Rev"},{"key":"2882_CR63","doi-asserted-by":"publisher","first-page":"103690","DOI":"10.1016\/j.jddst.2022.103690","volume":"75","author":"N Verma","year":"2022","unstructured":"Verma N, Arora V, Awasthi R, Chan Y, Jha NK, Thapa K, Jawaid T, Kamal M, Gupta G, Liu G, Paudel KR (2022) Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis. J Drug Del Sci Tech 75:103690. https:\/\/doi.org\/10.1016\/j.jddst.2022.103690","journal-title":"J Drug Del Sci Tech"},{"key":"2882_CR64","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmi.2021.11.022","volume":"28","author":"LL Wang","year":"2022","unstructured":"Wang LL, Yang JW, Xu JF (2022) Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury. ClinMicrobiol Infect 28:513\u2013520. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.022","journal-title":"ClinMicrobiol Infect"},{"key":"2882_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/jmatt202006006","volume":"3","author":"Y Xia","year":"2020","unstructured":"Xia Y, Ning P, Wang Z, Chen X (2020) Calming the cytokine storm in pneumonia by biomimetic nanoparticles. Matter 3:18\u201320. https:\/\/doi.org\/10.1016\/jmatt202006006","journal-title":"Matter"},{"key":"2882_CR66","doi-asserted-by":"publisher","first-page":"112023","DOI":"10.1016\/jenvres2021112023","volume":"204","author":"X Yang","year":"2022","unstructured":"Yang X, Zhang T, Zhang X, Chu C, Sang S (2022) Global burden of lung cancer attributable to ambient fine particulate matter pollution in 204 countries and territories, 1990\u20132019. Environ Res 204:112023. https:\/\/doi.org\/10.1016\/jenvres2021112023","journal-title":"Environ Res"},{"key":"2882_CR67","doi-asserted-by":"publisher","unstructured":"Yang X, Zhang T, Zhang Y, Chen H, Sang S (2021) Global burden of COPD attributable to ambient PM2.5 in 204 countries and territories, 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Sci Total Environ. 796 https:\/\/doi.org\/10.1016\/j.scitotenv.2021.148819","DOI":"10.1016\/j.scitotenv.2021.148819"},{"key":"2882_CR68","doi-asserted-by":"publisher","unstructured":"Zafar MS, Shahid K, Gobe GC, Yasmin R, Naseem N, Shahzad M(2022)Suppression of cytokine storm and associated inflammatory mediators by salicylaldehyde derivative of pregabalin: an innovative perspective for alleviating airway inflammation and lung remodeling. J King Saud Univ - Sci 34. https:\/\/doi.org\/10.1016\/jjksus2022101877","DOI":"10.1016\/jjksus2022101877"},{"key":"2882_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina58020144","volume":"58","author":"C Zanza","year":"2022","unstructured":"Zanza C, Romenskaya T, Manetti AC, Franceschi F, La Russa R, Bertozzi G, Maiese A, Savioli G, Volonnino G (2022) Cytokine storm in COVID-19: immunopathogenesis and therapy. Med 58:1\u201314. https:\/\/doi.org\/10.3390\/medicina58020144","journal-title":"Med"},{"issue":"6","key":"2882_CR70","doi-asserted-by":"publisher","first-page":"105982","DOI":"10.1016\/j.ijantimicag.2020.105982","volume":"55","author":"M Zhao","year":"2020","unstructured":"Zhao M (2020) Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies. Int J Antimicrob Agents 55(6):105982","journal-title":"Int J Antimicrob Agents"},{"key":"2882_CR71","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s12274-020-3180-3","volume":"14","author":"W Zhong","year":"2021","unstructured":"Zhong W, Zhang X, Zeng Y, Lin D, Wu J (2021) Recent applications and strategies in nanotechnology for lung diseases. Nano Res 14:2067\u20132089. https:\/\/doi.org\/10.1007\/s12274-020-3180-3","journal-title":"Nano Res"},{"key":"2882_CR72","doi-asserted-by":"publisher","first-page":"103951","DOI":"10.1016\/jebiom2022103951","volume":"78","author":"B Zhou","year":"2022","unstructured":"Zhou B, Zang R, Zhang M, Song P, Liu L, Bie F, Peng Y, Bai G, Gao S (2022) Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: a population-based study. EBioMedicine 78:103951. https:\/\/doi.org\/10.1016\/jebiom2022103951","journal-title":"EBioMedicine"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02882-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02882-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02882-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T08:17:38Z","timestamp":1716365858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02882-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2882"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02882-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}